| [1] | Johnson K (2008) PhRMA defends distribution of pharmaceutical samples. Available: http://www.phrma.org/news_room/press_rel？eases/phrma_defends_distribution_of_phar？maceutical_samples. Accessed 2 April 2009.
|
| [2] | Johnson K (2008) PhRMA statement on free pharmaceutical samples. Available: http://www.phrma.org/news_room/press_rel？eases/phrma_statement_on_free_pharmaceut？ical_samples/. Accessed 2 April 2009.
|
| [3] | Cutrona SL, Woolhandler S, Lasser KE, Bor DH, McCormick D, et al. (2008) Characteristics of recipients of free prescription drug samples: A nationally representative analysis. Am J Pub Health 98: 284–289.
|
| [4] | Limcangco MR, Stuart B, Briesacher B (2003) Do physicians use drug samples to increase access for needy patients? [abstract]. Academy Health Annual Meeting; 27 June 2003; Nashville, Tennessee, United States. Available: http://gateway.nlm.nih.gov/MeetingAbstra？cts/ma?f=102275615.html. Accessed 2 April 2009.
|
| [5] | Morelli DM, Koenignsberg MR (1992) Sample medication dispensing in a residency practice. J Fam Pract 34: 42–48.
|
| [6] | Westfall JM, McCabe J, Nicholas RA (1997) Personal use of drug samples by physicians and office staff. JAMA 278: 141–143.
|
| [7] | Tong KL, Lien C (1995) Do pharmaceutical representatives misuse their drug samples? Can Fam Physician 41: 1363–1366.
|
| [8] | Backer EL, Lebsack JA, Van Tonder RJN, Crabtree BF (2000) The value of pharmaceutical representative visits and medication samples in community-based family practices. J Fam Pract 49: 811–816.
|
| [9] | Topol EJ (2004) Failing the public health—Rofexicob, Merck, and the FDA. N Engl J Med 351: 1707–1709.
|
| [10] | Cutrona SL, Woolhandler S, Lasser KE, Bor DH, Himmelstein DU, et al. (2008) Free drug samples in the United States: Characteristics of pediatric recipients and safety concerns. Pediatrics 122: 736–742.
|
| [11] | Poser S (2007) Unlabeled prescription drug samples and the ‘learned intermediary’: The case for liability without preemption. Food Drug Law J 62: 653–694.
|
| [12] | [No authors listed] (2006 November 30) Verispan Reports: Samples have the most influence on physicians' prescribing habits. Business Wire. Available: http://findarticles.com/p/articles/mi_m0？EIN/is_/ai_n27070393. Accessed 2 April 2009.
|
| [13] | Morgan MA, Dana J, Loewenstein G, Zinberg S, Schulkin J (2006) Interactions of doctors with the pharmaceutical industry. J Med Ethics 32: 559–563.
|
| [14] | Groves KEM, Sketris I, Tett SE (2003) Prescription drug samples—Does this marketing strategy counteract policies for quality use of medicines? J Clin Pharm Ther 28: 259–271.
|
| [15] | Peay MY, Peay ER (1988) The role of commercial sources in the adoption of a new drug. Soc Sci Med 26: 1183–1189.
|
| [16] | Adair RF, Holmgren LR (2005) Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med 118: 881–884.
|
| [17] | Chew LD, O'Young TS, Hazlet TK, Bradley KA, Maynard C, et al. (2000) A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med 15: 478–483.
|
| [18] | [No authors listed] (2006) Samples. Café Pharma message boards. Available: http://www.cafepharma.com/boards/showthr？ead.php?t=109012. Accessed 7 April 2009.
|
| [19] | [No authors listed] (2007) Restricting samples. Café Pharma message boards. Available: http://www.cafepharma.com/boards/showthr？ead.php?t=116272. Accessed 2 April 2009.
|
| [20] | Petersen M (2000) Growing opposition to free drug samples; Ultimate costs and safety are cited. The New York Times. Available: http://query.nytimes.com/gst/fullpage.ht？ml?sec=health&res=9800E5DC163BF936A25752？C1A9669C8B63. Accessed 2 April 2009.
|
| [21] | Alexander GC, Zhang J, Basu A (2008) Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs. Med Care 46: 394–402.
|
| [22] | Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM (2002) Promotion of prescription drugs to consumers. N Engl J Med 346: 498–505.
|
| [23] | Gagnon M-A, Lexchin J (2008) The cost of pushing pills: A new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med 5: e1. doi:10.1371/journal.pmed.0050001.
|
| [24] | IMS Health (2004) Total US promotional spend by type, 2003. Fairfield (CT): IMS Health.
|
| [25] | Ipsos Ideas Library (2003) Is direct-to-consumer advertising for drug samples effective? Available: http://www.ipsos-ideas.com/article.cfm?i？d=2139. Accessed 2 April 2009.
|
| [26] | Kaiser Family Foundation (2008) Prescription drug trends. Available: http://www.kff.org/rxdrugs/upload/3057_0？7.pdf. Accessed 2 April 2009.
|
| [27] | Pear R (2006 January 10) Growth of national health spending slows along with drug sales. The New York Times. Available: http://www.nytimes.com/2006/01/10/nation？al/10health.html. Accessed 2 April 2009.
|
| [28] | Kaiser Family Foundation (2004) Prescription drug trends. Available: http://www.kff.org/rxdrugs/upload/Prescr？iption-Drug-Trends-October-2004-UPDATE.p？df. Accessed 2 April 2009.
|
| [29] | The National Institute for Health Care Management Research and Educational Foundation (2001) Prescription drugs and mass media advertising, 2000. Available: http://www.nihcm.org/？nihcmor/pdf/DTCbri？ef2001.pdf. Accessed 2 April 2009.
|
| [30] | The National AcademiesInstitute of Medicine (2006) Medication errors injure 1.5 million people and cost billions of dollars annually; Report offers comprehensive strategies for reducing drug-related mistakes. Available: http://www8.nationalacademies.org/onpine？ws/newsitem.aspx?RecordID=11623. Accessed 2 April 2009.
|
| [31] | American Society of Health-System Pharmacists (2006) Drug samples (policy position 9702). Available: http://www.ashp.org/s_ashp/doc1c.asp?CID？=512&DID=7300#9702. Accessed 2 April 2009.
|
| [32] | Charatan F (2000) Hospital bans free drug samples. West J Med 174: 236–237.
|
| [33] | Association of American Medical Colleges (2008) Industry funding of medical education: Report of an AAMC Task Force. Available: https://services.aamc.org/Publications/s？howfile.cfm?file=version114.pdf&prd_id=2？32&prv_id=281&pdf_id=114. Accessed 2 April 2009.
|
| [34] | Association of Faculties of Medicine of Canada (2008) Association of Faculties of Medicine of Canada Endorses AAMC policies regarding industry funding of medical education. Available: http://www.afmc.ca/news-whats-new-detail？s-e.php?id=85. Accessed 2 April 2009.
|
| [35] | Rx Outreach (2009) Patient assistance program for discount prescription drugs. Available: http://rxoutreach.com. Accessed 2 April 2009.
|
| [36] | Associated Press (2006 October 26) Wal-Mart adds 12 states to $4 generic drug plan; Total now 27. USA Today. Available: http://www.usatoday.com/money/industries？/retail/2006-10-26-walmart-drugs_x.htm. Accessed 2 April 2009.
|
| [37] | The Prescription Project (2008) Samples: Best practices for academic medical centers. Available: http://www.imapny.org/usr_doc/amc/Sample？s.doc. Accessed 2 April 2009.
|
| [38] | Jordan E (2009 January 23) U of I to bar free drug samples, gifts. DesMoines Register. Available: http://www.pharmfree.org/news?id=0022. Accessed 2 April 2009.
|
| [39] | University of Wisconsin-Madison (2009) Policy recommendations from the Task Force on Industry Conflict of Interest in the Clinical Setting. Available: http://media.jsonline.com/documents/uwdo？csclinical022709.pdf. Accessed 2 April 2009.
|
